Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment

Clinical Endocrinology

Volumn 70, Issue 3, 2009, Pages 475-483

  Camacho, Cléber P ^b,c   Latini, Flavia R M ^b,c   Oler, Gisele ^b,c   Hojaij, Flavio C ^a   MacIel, Rui M B ^c   Riggins, Gregory J ^d   Cerutti, Janete M ^a,b,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Division of Genetics   (Brazil)

^c Department of Medicine   (Brazil)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CARCINOMA CELL; CCDN1 GENE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; FOSB GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE LIBRARY; GENE LOSS; GENETIC CORRELATION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; MUTATION; NR4A1 GENE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; THYROID ADENOMA; THYROID CELL; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; WNT GENE;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; CYCLIN D1; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; LITHIUM; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; WNT PROTEINS;

EID: 60349116158     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03349.x     Document Type: Article

References (57)

1. Davies, L. Welch, H.G. (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. The Journal of the American Medical Association, 295, 2164 2167.
2. Kimura, E.T., Nikiforova, M.N., Zhu, Z. et al. (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research, 63, 1454 1457.
3. Viglietto, G., Chiappetta, G., Martinez-Tello, F.J. et al. (1995) RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene, 11, 1207 1210.
4. Soares, P., Trovisco, V., Rocha, A.S. et al. (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene, 22, 4578 4580.
5. Marques, A.R., Espadinha, C., Catarino, A.L. et al. (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 87, 3947 3952.
6. Cheung, L., Messina, M., Gill, A. et al. (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 88, 354 357.
7. Nakabashi, C.C., Guimaraes, G.S., Michaluart, P. Jr et al. (2004) The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma. Clinical Endocrinology, 61, 280 282.
8. Nikiforova, M.N., Lynch, R.A., Biddinger, P.W. et al. (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 2318 2326.
9. Kroll, T.G., Sarraf, P., Pecciarini, L. et al. (2000) PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science, 289, 1357 1360.
10. Cheng, G., Lewis, A.E. Meinkoth, J.L. (2003) Ras stimulates aberrant cell cycle progression and apoptosis in rat thyroid cells. Molecular Endocrinology, 17, 450 459.
11. Nikiforova, M.N., Biddinger, P.W., Caudill, C.M. et al. (2002) PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. American Journal of Surgery Pathology, 26, 1016 1023.
12. Cerutti, J.M., Delcelo, R., Amadei, M.J. et al. (2004) A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. Journal of Clinical Investigation, 113, 1234 1242.
13. Cerutti, J.M., Latini, F.R., Nakabashi, C. et al. (2006) Diagnosis of suspicious thyroid nodules using four protein biomarkers. Clinical Cancer Research, 12, 3311 3318.
14. Aranda, A. Pascual, A. (2001) Nuclear hormone receptors and gene expression. Physiological Reviews, 81, 1269 1304.
15. Wu, Q., Liu, S., Ye, X.F. et al. (2002) Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells. Carcinogenesis, 23, 1583 1592.
16. Chtarbova, S., Nimmrich, I., Erdmann, S. et al. (2002) Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activation. The Biochemical Journal, 367, 723 728.
17. Weih, F., Ryseck, R.P., Chen, L. et al. (1996) Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proceedings of the National Academy of Sciences of the USA, 93, 5533 5538.
18. Chintharlapalli, S., Burghardt, R., Papineni, S. et al. (2005) Activation of Nur77 by selected 1,1-Bis (3′-indolyl) -1-(, p. -substituted phenyl) methanes induces apoptosis through nuclear pathways. Journal of Biological Chemistry, 280, 24903 24914.
19. Maxwell, M.A. Muscat, G.E. (2006) The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nuclear Receptor Signaling, 4, 1 8.
20. Briere, J., Pousset, G., Darsy, P. et al. (1974) The advantage of lithium in association with iodine 131 in the treatement of functioning metastasis of the thyroid cancer. Annales D'endocrinologie, 35, 281 282.
21. Koong, S.S., Reynolds, J.C., Movius, E.G. et al. (1999) Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 84, 912 916.
22. van Staveren, W.C., Solis, D.W., Delys, L. et al. (2007) Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Research, 67, 8113 8120.
23. Matsuo, K., Tang, S.H., Sharifi, B. et al. (1993) Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line. Journal of Clinical Endocrinology and Metabolism, 77, 996 1004.
24. Estour, B., Van Herle, A.J., Juillard, G.J. et al. (1989) Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Archiv B, Cell Pathology Including Molecular Pathology, 57, 167 174.
25. de Nigris, F., Cerutti, J., Morelli, C. et al. (2002) Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues. British Journal of Cancer, 86, 917 923.
26. Arnaldi, L.A., Borra, R.C., Maciel, R.M. et al. (2005) Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors. Thyroid, 15, 210 221.
27. Cerutti, J.M., Ebina, K.N., Matsuo, S.E. et al. (2003) Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines. Journal of Endocrinological Investigation, 26, 516 521.
28. Cerutti, J.M., Oler, G., Michaluart, P. Jr et al. (2007) Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis. Cancer Research, 67, 7885 7892.
29. Rao, A.S., Kremenevskaja, N., Resch, J. et al. (2005) Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. European Journal of Endocrinology, 153, 929 938.
30. Latini, F., Hemerly, J., Oler, G. et al. (2008) Re-expression of ABI3 BP suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. Endocrine-Related Cancer, 15, 787 799.
31. Boon, K., Osorio, E.C., Greenhut, S.F. et al. (2002) An anatomy of normal and malignant gene expression. Proceedings of the National Academy of Sciences of the USA, 99, 11287 11292.
32. Mao, C.D., Hoang, P. DiCorleto, P.E. (2001) Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells. Journal of Biological Chemistry, 276, 26180 26188.
33. Li, Y., Lin, B., Agadir, A. et al. (1998) Molecular determinants of AHPN (CD437) -induced growth arrest and apoptosis in human lung cancer cell lines. Molecular and Cellular Biology, 18, 4719 4731.
34. Woronicz, J.D., Calnan, B., Ngo, V. et al. (1994) Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature, 367, 277 281.
35. Pekarsky, Y., Hallas, C., Palamarchuk, A. et al. (2001) Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proceedings of the National Academy of Sciences of the USA, 98, 3690 3694.
36. Fujii, Y., Matsuda, S., Takayama, G. et al. (2008) ERK5 is involved in TCR-induced apoptosis through the modification of Nur77. Genes to Cells, 13, 411 419.
37. Li, H., Kolluri, S.K., Gu, J. et al. (2000) Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science, 289, 1159 1164.
38. Lin, B., Kolluri, S.K., Lin, F. et al. (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell, 116, 527 540.
39. Mullican, S.E., Zhang, S., Konopleva, M. et al. (2007) Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nature Medicine, 13, 730 735.
40. Hazel, T.G., Nathans, D. Lau, L.F. (1988) A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proceedings of the National Academy of Sciences of the USA, 85, 8444 8448.
41. Schou, M., Amdisen, A., Eskjaer Jensen, S. et al. (1968) Occurrence of goitre during lithium treatment. British Medical Journal, 3, 710 713.
42. Temple, R., Berman, M., Robbins, J. et al. (1972) The use of lithium in the treatment of thyrotoxicosis. Journal of Clinical Investigation, 51, 2746 2756.
43. Pacini, F., Schlumberger, M., Dralle, H. et al. (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology, 154, 787 803.
44. Cooper, D.S., Doherty, G.M., Haugen, B.R. et al. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 16, 109 142.
45. Sibayama-Imazu, T., Fujisawa, Y., Masuda, Y. et al. (2008) Induction of apoptosis in PA-1 ovarian cancer cells by vitamin K (2) is associated with an increase in the level of TR3/Nur77 and its accumulation in mitochondria and nuclei. Journal of Cancer Research Clinical Oncology, 134, 803 812.
46. Stambolic, V., Ruel, L. Woodgett, J.R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology, 6, 1664 1668.
47. Kappes, A., Vaccaro, A., Kunnimalaiyaan, M. et al. (2007) Lithium ions: a novel treatment for pheochromocytomas and paragangliomas. Surgery, 141, 161 165.
48. Kunnimalaiyaan, M., Vaccaro, A.M., Ndiaye, M.A. et al. (2007) Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Molecular Cancer Therapy, 6, 1151 1158.
49. Giles, R.H., van Es, J.H. Clevers, H. (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochemica Biophysica Acta, 1653, 1 24.
50. Penso, J. Beitner, R. (2003) Lithium detaches hexokinase from mitochondria and inhibits proliferation of B16 melanoma cells. Molecular Genetics and Metabolism, 78, 74 78.
51. Karlovic, D., Jakopec, S., Dubravcic, K. et al. (2007) Lithium increases expression of p21 (WAF/Cip1) and survivin in human glioblastoma cells. Cell Biology and Toxicology, 23, 83 90.
52. Tetsu, O. McCormick, F. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422 426.
53. Tice, D.A., Soloviev, I. Polakis, P. (2002) Activation of the Wnt pathway interferes with serum response element-driven transcription of immediate early genes. Journal of Biological Chemistry, 277, 6118 6123.
54. Meirmanov, S., Nakashima, M., Kondo, H. et al. (2003) Correlation of cytoplasmic beta-catenin and cyclin D1 overexpression during thyroid carcinogenesis around Semipalatinsk nuclear test site. Thyroid, 13, 537 545.
55. Huang, Y., Prasad, M., Lemon, W.J. et al. (2001) Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proceedings of the National Academy of Sciences of the USA, 98, 15044 15049.
56. Melillo, R.M., Castellone, M.D., Guarino, V. et al. (2005) The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. Journal of Clinical Investigation, 115, 1068 1081.
57. Puxeddu, E., Moretti, S., Giannico, A. et al. (2003) Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. European Journal of Endocrinology, 148, 505 513.